An extension study to evaluate the outcomes of patients treated with extracorporeal hepatocyte based therapy
Latest Information Update: 24 Feb 2020
At a glance
- Drugs Extracorporeal hepatocyte-based therapy (Primary)
- Indications Alcoholic hepatitis; Liver failure
- Focus Therapeutic Use
- 02 Sep 2015 New trial record
- 31 Aug 2015 Data from this trial were presented at the 16th International Symposium on Albumin Dialysis in Liver Disease according to a Vital Therapies media release.